Door to balloon time in primary percutaneous coronary intervention in ST elevation myocardial infarction: every

Erez Marcusohn1, Anat Reiner Benaim2, Shay Ronen3

  • 1Department of Cardiology, Rambam Health Care Campus, Haifa.

Insights

Shorter door-to-balloon (D2B) times significantly reduce mortality and acute coronary syndrome (ACS) recurrence in ST-elevation myocardial infarction patients. However, D2B time did not impact heart failure admissions within one year.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Health Services Research

Background:

  • Current guidelines recommend a 90-minute door-to-balloon (D2B) time for primary percutaneous coronary intervention (PPCI).
  • Meeting this D2B goal is associated with reduced mortality and adverse cardiovascular events.

Purpose of the Study:

  • To examine the relationship between D2B time and subsequent heart failure (HF) admissions, acute coronary syndrome (ACS) recurrence, and mortality.
  • To evaluate the impact of D2B times on patient outcomes up to one year post-PPCI.

Main Methods:

  • Retrospective analysis of 826 ST-elevation myocardial infarction patients undergoing PPCI from 2013-2019.
  • Data collected included D2B time, clinical characteristics, and outcomes (HF, ACS, mortality).
  • Multivariate Cox models were used to calculate adjusted hazard ratios (HR).

Main Results:

  • No significant effect of D2B time on heart failure admissions was observed.
  • Increased D2B time was associated with higher mortality at 180 days (HR 1.308 per 30-min increase).
  • D2B time significantly impacted ACS recurrence, with a 30-minute cutoff showing increased recurrence up to 1 year.

Conclusions:

  • Shorter D2B times correlate with reduced mortality and ACS recurrence.
  • D2B time does not appear to influence the incidence of heart failure admissions.
  • Optimizing D2B times remains crucial for improving outcomes in STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
142